accountSAN DIEGO, Oct. 30 /PRNewswire-FirstCall/ -- In a speech today to the City Club of San Diego, John C. Lechleiter, Ph.D., chairman and chief executive officer of Eli Lilly and Company (NYSE: LLY), said that the engine of biopharmaceutical innovation...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Lilly CEO Lechleiter Calls for Repair of the 'Engine of Biopharma Innovation'Speech at the City Club of San Diego Outlines Changes for Better Medicine
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
